NOTE TO READERS: When this project lost substantial funding at the end of 2018, I lost the ability to continue publishing criteria-driven news story reviews and PR news release reviews - once the bread-and-butter of the site going back to 2006. The 3,200 archived reviews, while still educational, are getting old and difficult for me to technically maintain on the back end of the website. So I am announcing that I plan to remove these reviews from the site by April 1, 2021. The blog and the toolkit - two of the most popular features on the site - will remain. If you wish to peruse the reviews before they disappear, please do so by the end of March 2021. After that date you may still be able to access them via the Internet Archive Wayback Machine - https://archive.org/web/.

Tag: stem cells

This page contains all our major blog content on stem cell treatment, research, therapies, #stemcellhype and more.

1 10/24/2018

Medical crowdfunding steers millions in donations to dangerous snake oil

8/7/2018

Headline vs. study: Promises for your heart, brain, and the common flu

2 5/24/2018

In portraying a silver lining to Santa Fe school shooting, news stories mislead public about GoFundMe campaign for victim’s husband

5/9/2018

Crowdfunding’s dark side: When patients seek help paying for stem cell treatments, misinformation rules

2 2/27/2018

News coverage of crowdfunding appeals may help some people, but hidden costs are steep

2/1/2018

Animated map illustrates ‘wildfire spread’ of unregulated stem cell clinics in U.S.

12/5/2017

Smithsonian’s imbalanced stem cell coverage: Will it help dodgy clinics lure desperate patients?

1 11/2/2017

In need of scrutiny: Misleading stem cell claims by academic medical centers

9/6/2017

Headline vs. study: Stem cells ‘slow aging’ and ‘rejuvenate’ old hearts

8/29/2017

FDA announces action against two stem cell clinics: Is that a ‘crackdown’?    

Blog

Opinions on other issues in news, journals, PR, advertising, marketing

@HealthNewsRevu

HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Our 3,222 reviews of health care journalism & PR will be gone soon. The rest of the website will remain. Read details. https://www.healthnewsreview.org/2021/01/our-3222-systematic-reviews-of-journalism-pr-will-be-gone-soon/

Reply on Twitter 1351160348615782403Retweet on Twitter 13511603486157824032Like on Twitter 13511603486157824032Twitter 1351160348615782403
HealthNewsRevuHealthNewsReview.org@HealthNewsRevu·

Year-ender: links to all 44 articles I published in 2020 - a year of too-frequent distortion, deceit and misinformation, worst I’ve seen in my 47-year career. https://www.healthnewsreview.org/2020/12/reflections-on-2020-you-cant-mask-this-reality/

Reply on Twitter 1343561730203525122Retweet on Twitter 13435617302035251229Like on Twitter 13435617302035251227Twitter 1343561730203525122
Retweet on TwitterHealthNewsReview.org Retweeted
IJNetIJNet@IJNet·

“The distinction between what we do know and what we do not yet understand should be explained more often and more clearly in our coverage,” said @garyschwitzer. Journalists need to get past press releases from drug companies, but also debunk conspiracies. https://buff.ly/2LX9MVo

Reply on Twitter 1342696898508029952Retweet on Twitter 13426968985080299525Like on Twitter 13426968985080299529Twitter 1342696898508029952
View More

Categories

View More

Tags